Materialize (MTLS) last week saw unusual 4000 May $10 calls buy to open and shares are already +30% YTD moving to multi-year highs out of a weekly bull flag. The recent results and move in SSYS has brought interest back to the 3D Printing stocks. MTLS will next report on 2-20.

Materialise NV provides additive manufacturing and medical software, and 3D printing services, operating through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing.

MTLS has a market cap of $527.5M and trades 33.1X Earnings, 11.1X EBITDA and 4X Cash with revenues seen rising 8.35% in 2025 with 24% EPS growth. Medical has been a standout grower and now accounts for 44% of revenues. MTLS continues to further penetrate a large opportunity for trauma patients. Its Mimics Innovation Suite is used by researchers and engineers to segment the medical images of the patients, create a 3D model, and prepare the treatment plan on this basis or design patient-specific implant or instrument for the patient at hand.

MTLS is a relatively cheap and more financially sound way to play the future of 3D Printing and Additive Manufacturing with a focus on the vast potential across medical.